RetinalGenix Technologies (RTGN) Payables (2020 - 2026)

RetinalGenix Technologies (RTGN) has 7 years of Payables data on file, last reported at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Payables rose 34.13% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 34.13% YoY), and the FY2025 full-year result was $1.1 million, up 22.96% from the prior year.
• Payables climbed to $1.2 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Payables ranged from a high of $1.2 million in Q1 2026 to a low of $262467.0 in Q1 2022.
• A 5-year average of $784909.0 and a median of $862453.0 in 2024 frame the typical range for Payables.
• Across the five-year window, Payables surged 141.62% in 2023 and increased 4.2% in 2024, its largest moves.
• Tracing RTGN's Payables over 5 years: stood at $524480.0 in 2022, then jumped by 68.72% to $884920.0 in 2023, then climbed by 4.2% to $922083.0 in 2024, then increased by 22.96% to $1.1 million in 2025, then grew by 9.24% to $1.2 million in 2026.
• Business Quant data shows RTGN's Payables at $1.2 million in Q1 2026, $1.1 million in Q4 2025, and $1.0 million in Q3 2025.